{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:45:17Z","timestamp":1788284717608,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ejpb.2009.02.006","type":"journal-article","created":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T09:16:17Z","timestamp":1234775777000},"page":"487-495","source":"Crossref","is-referenced-by-count":50,"title":["Bioadhesive sulfacetamide sodium microspheres: Evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model"],"prefix":"10.1016","volume":"72","author":[{"given":"Demet","family":"Sensoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdal","family":"Cevher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Sar\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif","family":"\u00d6zdamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazan","family":"Bergi\u015fadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2009.02.006_bib1","series-title":"The Cornea","author":"Kaufman","year":"1988"},{"key":"10.1016\/j.ejpb.2009.02.006_bib2","series-title":"Duane\u2019s Clinical Ophthalmology","first-page":"1","article-title":"Bacterial corneal ulcers","author":"Abbot","year":"1994"},{"key":"10.1016\/j.ejpb.2009.02.006_bib3","series-title":"Modern Ophthalmology","first-page":"200","article-title":"Corneal ulcer","author":"Reddy","year":"2000"},{"key":"10.1016\/j.ejpb.2009.02.006_bib4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.87.7.834","article-title":"Bacterial keratitis: predisposing factors clinical and microbiological review of 300 cases","volume":"87","author":"Bourcier","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib5","series-title":"Cornea: Cornea and External Diseases; Clinical Diagnosis and Management","first-page":"1139","article-title":"Bacterial keratitis","author":"O\u2019Brien","year":"1997"},{"key":"10.1016\/j.ejpb.2009.02.006_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/bjo.84.7.687","article-title":"In vitro antibiotic resistance in bacterial keratitis in London","volume":"84","author":"Tuft","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1076\/ceyr.23.1.60.5417","article-title":"The effectiveness of tobramycin and Ocuflox\u00ae in a prophylaxis model of Staphylococcus keratitis","volume":"23","author":"Dajcs","year":"2001","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2009.02.006_bib8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/bjo.81.12.1060","article-title":"Bacterial keratitis in the critically ill","volume":"81","author":"Parkin","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(98)09385-4","article-title":"Incidence of contact-lens-associated microbial keratitis and its related morbidity","volume":"354","author":"Cheng","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2009.02.006_bib10","series-title":"Disease of the External Eye and Adnexa","first-page":"137","article-title":"Disease of cornea","author":"Ostler","year":"1993"},{"key":"10.1016\/j.ejpb.2009.02.006_bib11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bjo.85.7.842","article-title":"Bacterial keratitis: a prospective clinical and microbiological study","volume":"85","author":"Schaefer","year":"2001","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.eye.6700635","article-title":"Management of bacterial keratitis: beyond exorcism towards consideration of organism and host factors","volume":"17","author":"O\u2019Brien","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2009.02.006_bib13","first-page":"2S","article-title":"A review of bacterial keratitis and bacterial conjunctivitis","volume":"112","author":"Limberg","year":"1991","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1128\/CMR.7.3.357","article-title":"The medically important aerobic actinomycetes: epidemiology and microbiology","volume":"7","author":"McNeil","year":"1994","journal-title":"Clin. Microb. Rev."},{"key":"10.1016\/j.ejpb.2009.02.006_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0039-6257(00)00207-1","article-title":"Ocular Nocardia infections with special emphasis on the cornea","volume":"45","author":"Sridhar","year":"2001","journal-title":"Survey Ophthalmol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2008-1045735","article-title":"The effective antibacterial spectrum of sulfacetamide","volume":"200","author":"Roth","year":"1992","journal-title":"Klin. Monatsbl. Augenheilkd."},{"key":"10.1016\/j.ejpb.2009.02.006_bib17","first-page":"1218","article-title":"Ocular evaluation of methylcellulose vehicle in rabbits","volume":"68","author":"Chrai","year":"1984","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2009.02.006_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0378-5173(94)00389-M","article-title":"Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye","volume":"118","author":"Durrani","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2009.02.006_bib19","first-page":"628","article-title":"Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use","volume":"57","author":"Harmann","year":"2000","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2009.02.006_bib20","first-page":"11","article-title":"The role of hydrogen bonding in adhesion","volume":"6","author":"Pritchard","year":"1971","journal-title":"Aspects Adhes."},{"key":"10.1016\/j.ejpb.2009.02.006_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0168-3659(85)90032-X","article-title":"Physico-chemical properties of water insoluble polymers important to mucin\/epithelial adhesion","volume":"2","author":"Park","year":"1985","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2009.02.006_bib22","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1248\/cpb.37.1366","article-title":"Factors affecting the bioadhesive properties of tablets consisting of hydroxypropyl cellulose and carboxy vinyl polymers","volume":"37","author":"Satoh","year":"1989","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2009.02.006_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0378-5173(92)90043-2","article-title":"Bioadhesion: the effect of polyacrylic acid on the ocular bioavailability of timolol","volume":"81","author":"Thermes","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2009.02.006_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-409X(95)00017-2","article-title":"Microspheres and nanoparticles used in ocular delivery systems","volume":"16","author":"Zimmer","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2009.02.006_bib25","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1211\/0022357022476","article-title":"The potential of chitosan in ocular drug delivery","volume":"55","author":"Alonso","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1211\/0022357991772664","article-title":"Characterization and in-vivo ocular absorption of liposome-encapsulated acyclovir","volume":"51","author":"Fresta","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-3659(99)00192-3","article-title":"Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption","volume":"63","author":"Law","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2009.02.006_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5","article-title":"Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanospheres-encapsulated acyclovir","volume":"90","author":"Fresta","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2009.02.006_bib29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2009.02.006_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/02652040400008515","article-title":"Polycarboxylic acid nanoparticles for ophthalmic drug delivery: an ex vivo evaluation with human cornea","volume":"21","author":"De","year":"2004","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2009.02.006_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.10.026","article-title":"Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system","volume":"290","author":"Aggarwal","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2009.02.006_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2007.09.004","article-title":"The use of fucosphere in the treatment of superficial partial thickness burns in rabbits","volume":"69","author":"Sezer","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2009.02.006_bib33","series-title":"Biopharmaceutics of Ocular Drug Delivery","first-page":"1","article-title":"Anatomy and physiology of the eye: physiological aspects of ocular drug therapy","author":"Stjemschantz","year":"1993"},{"key":"10.1016\/j.ejpb.2009.02.006_bib34","unstructured":"National Research Council (NRC), Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, USA, 1996."},{"key":"10.1016\/j.ejpb.2009.02.006_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajo.2004.03.016","article-title":"A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa","volume":"138","author":"Rhee","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ajo.2005.01.021","article-title":"The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model","volume":"139","author":"Romanowski","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2009.02.006_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2006.03.014","article-title":"Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres","volume":"317","author":"Cevher","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2009.02.006_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(99)00023-8","article-title":"Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits","volume":"9","author":"Giunchedi","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2009.02.006_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1302\/0301-620X.88B2.16328","article-title":"The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres. Their evaluation in an animal osteomyelitis model","volume":"88-B","author":"Orhan","year":"2006","journal-title":"J. Bone Joint Surg."},{"key":"10.1016\/j.ejpb.2009.02.006_bib40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3109\/03639049209043712","article-title":"In vitro evaluation of spray-dried mucoadhesive microspheres for nasal administration","volume":"18","author":"Vidgren","year":"1992","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2009.02.006_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0939-6411(01)00124-2","article-title":"Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxycillin\u2013resin complexes for drug delivery to the gastric mucosa","volume":"51","author":"Cu\u00f1a","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2009.02.006_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0168-3659(87)90090-3","article-title":"Design and evaluation of controlled release systems for the eye","volume":"6","author":"Gurny","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2009.02.006_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0378-5173(85)90230-3","article-title":"Ocular delivery of progesterone using a bioadhesive polymer","volume":"26","author":"Hui","year":"1985","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2009.02.006_bib44","series-title":"Ophthalmic Drug Delivery Systems","first-page":"409","article-title":"Mucoadhesive polymers in ophthalmic drug delivery","author":"Johnston","year":"2003"},{"key":"10.1016\/j.ejpb.2009.02.006_bib45","unstructured":"A. Gottschalk, The Chemistry and Biology of Sialic Acid and Related Substances, Cambridge University Press, London."},{"key":"10.1016\/j.ejpb.2009.02.006_bib46","first-page":"705","article-title":"Systems for controlled release of drug. V. Bioadhesive systems","volume":"2","author":"Mikos","year":"1986","journal-title":"S.T.P. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2009.02.006_bib47","first-page":"2809","article-title":"Improved ocular penetration of gentamicin by mucoadhesive polymer in the pigmented rabbit","volume":"35","author":"Lehr","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2009.02.006_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0169-409X(93)90016-W","article-title":"Treatment of diseases of the eye with mucoadhesive delivery systems","volume":"11","author":"Greaves","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2009.02.006_bib49","first-page":"322","article-title":"Acceptability of thickened eye drops to human subjects","volume":"33","author":"Dudinski","year":"1983","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.ejpb.2009.02.006_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0169-409X(95)00015-Y","article-title":"Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels","volume":"16","author":"Zignani","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2009.02.006_bib51","first-page":"357","article-title":"Evaluation of gentamicin-Eudragit microspheres as ophthalmic delivery systems in inflamed rabbit\u2019s eye","volume":"12","author":"Safwat","year":"2002","journal-title":"S.T.P. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641109000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641109000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T19:56:40Z","timestamp":1545422200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641109000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0939641109000630"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2009.02.006","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}